October 2021 Immunization Guide for Pharmacists

The Role of Student Pharmacists in the Immunization Process at Northeastern University

ByMichelle Jacobs, PharmD, RPh, BCACP, CDCES,Macayla A. Bartucca, PharmD, BCPS, BCGP,Mark A. Douglass, PharmD,Michael J. Gonyeau, PharmD, MEd, BS, BCPS, FNAP, FCCP,Thomas M. Matta, PharmD, CDCES, AE-C,Danielle M. Miller, PharmD, MEd, RPh, BCACP,Tayla N. Rose, PharmD, MEd, RPh, BCACP, CDCES,David Zgarrick, RPh, PhD, FAPhA

October 27th 2021

Addressing Vaccine Hesitancy Among Health Care Workers

ByAleda M. H. Chen, PharmD, PhD, FAPhA,Justin W. Cole, PharmD, BCPS

October 26th 2021

Although there is no one-size-fits-all approach to promoting vaccine confidence, a conversation is a great starting point.

Using mRNA to Create the Elusive HIV Vaccine

ByChristina M. Madison, PharmD, FCCP, AAHIVP

October 25th 2021

The success of the COVID-19 messenger RNA (mRNA) vaccines from Pfizer/BioNTech and Moderna has given many HIV advocates hope that a preventive mRNA vaccine is on the horizon.

COVID-19 Vaccines: FDA Approved, EUA, and in the Pipeline

ByJamie L. Wagner, PharmD, BCPS,Erin M. Johnson, PharmD Candidate,Hannah C. Oliver, PharmD Candidate

October 19th 2021

Clinical testing of COVID-19 vaccine efficacy has led to the first FDA-approved COVID-19 vaccine, Comirnaty.

New Vaccines for 2021 and the Vaccine Development Pipeline

ByMary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP

October 18th 2021

October 2021 Immunization Guide for Pharmacists

The Role of Student Pharmacists in the Immunization Process at Northeastern University

Addressing Vaccine Hesitancy Among Health Care Workers

Using mRNA to Create the Elusive HIV Vaccine

COVID-19 Vaccines: FDA Approved, EUA, and in the Pipeline

New Vaccines for 2021 and the Vaccine Development Pipeline

Trending on Pharmacy Times

FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief

FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure

Q&A: Pharmacists' Role in CKD Grows as Finerenone Eyes Label Expansion

Two Weeks In: What the Medicare GLP-1 Bridge Actually Looks Like at the Counter

Lilly Prepares for Retatrutide FDA Filing Following Additional Phase 3 Data in Diabetes, CVD